{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 110,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n"
     ]
    }
   ],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "from statsmodels.nonparametric.smoothers_lowess import lowess\n",
    "from clust_huge_amp import *\n",
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\", category=RuntimeWarning, module=\"sklearn.utils.extmath\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Running the model for prediction tasks\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Here we demonstrate model initialization for a model that will ultimately use data only at enrollment for prediction tasks. We initialize the model as in for retrospective tasks, but we modify the Censoring matrix E such that an individual's event times are capped at the minimum of event time or age of recruitment, whicever comes first.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n",
      "Loading components...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/432458031.py:24: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  Y = torch.load(base_path + 'Y_tensor.pt')\n",
      "/var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/432458031.py:25: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  E = torch.load(base_path + 'E_matrix.pt')\n",
      "/var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/432458031.py:26: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  G = torch.load(base_path + 'G_matrix.pt')\n",
      "/var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/432458031.py:29: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  essentials = torch.load(base_path + 'model_essentials.pt')\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded all components successfully!\n"
     ]
    }
   ],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "\n",
    "\n",
    "\n",
    "%autoreload 2\n",
    "import numpy as np\n",
    "import torch\n",
    "import torch.nn as nn\n",
    "import torch.optim as optim\n",
    "from scipy.spatial.distance import pdist, squareform\n",
    "from scipy.special import expit\n",
    "from scipy.stats import multivariate_normal\n",
    "import matplotlib.pyplot as plt\n",
    "from sklearn.cluster import SpectralClustering  # Add this import\n",
    "\n",
    "def load_model_essentials(base_path='/Users/sarahurbut/Library/CloudStorage/Dropbox/data_for_running/'):\n",
    "    \"\"\"\n",
    "    Load all essential components\n",
    "    \"\"\"\n",
    "    print(\"Loading components...\")\n",
    "    \n",
    "    # Load large matrices\n",
    "    Y = torch.load(base_path + 'Y_tensor.pt')\n",
    "    E = torch.load(base_path + 'E_matrix.pt')\n",
    "    G = torch.load(base_path + 'G_matrix.pt')\n",
    "    \n",
    "    # Load other components\n",
    "    essentials = torch.load(base_path + 'model_essentials.pt')\n",
    "    \n",
    "    print(\"Loaded all components successfully!\")\n",
    "    \n",
    "    return Y, E, G, essentials\n",
    "\n",
    "# Load and initialize model:\n",
    "Y, E, G, essentials = load_model_essentials()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [],
   "source": [
    "from clust_huge_amp import *\n",
    "# Subset the data\n",
    "#Y_100k, E_100k, G_100k, indices = subset_data(Y, E, G, start_index=0, end_index=10000)\n",
    "\n",
    "Y_100k, E_100k, G_100k, indices = subset_data(Y, E, G, start_index=20000, end_index=30000)\n",
    "\n",
    "torch.manual_seed(42)\n",
    "np.random.seed(42)\n",
    "if torch.cuda.is_available():\n",
    "    torch.cuda.manual_seed(42)\n",
    "torch.backends.cudnn.deterministic = True\n",
    "torch.backends.cudnn.benchmark = False\n",
    "# Initialize model with subsetted data\n",
    "\n",
    "del Y"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/3625861070.py:2: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  refs = torch.load('/Users/sarahurbut/Library/CloudStorage/Dropbox/data_for_running/reference_trajectories.pt')\n"
     ]
    }
   ],
   "source": [
    "# Load references (signatures only, no healthy)\n",
    "refs = torch.load('/Users/sarahurbut/Library/CloudStorage/Dropbox/data_for_running/reference_trajectories.pt')\n",
    "signature_refs = refs['signature_refs']\n",
    "# When initializing the model:\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "407878"
      ]
     },
     "execution_count": 114,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "fh_processed=pd.read_csv('/Users/sarahurbut/Library/Cloudstorage/Dropbox/baselinagefamh.csv')\n",
    "len(fh_processed)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "You can see that we take the event times and cap them at the enrollment time or the age of event, whichever occurs first, so if someone has an event prior to enrollment that age (index) is preserved but there is no `leakage of inofrmaiton from the future"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [],
   "source": [
    "# Create enrollment-time-aware E matrix\n",
    "E_enrollment = E_100k.clone()  # Start with the original censoring times\n",
    "\n",
    "# For each patient, cap event/censoring times at their enrollment time\n",
    "pce_df_subset = fh_processed.iloc[20000:30000].reset_index(drop=True)\n",
    "#pce_df_subset = fh_processed.iloc[0:10000].reset_index(drop=True)\n",
    "for patient_idx, row in enumerate(pce_df_subset.itertuples()):\n",
    "    if patient_idx >= E_enrollment.shape[0]:  # Make sure we don't go out of bounds\n",
    "        break\n",
    "        \n",
    "    # Calculate enrollment time (age at enrollment - 30)\n",
    "    enroll_time = int(row.age - 30)\n",
    "    \n",
    "    if enroll_time >= 0:  # Make sure enrollment time is valid\n",
    "        # Cap all disease times to be at most the enrollment time\n",
    "        # This is the key step: min(original_event_time, enrollment_time)\n",
    "        E_enrollment[patient_idx, :] = torch.minimum(\n",
    "            E_enrollment[patient_idx, :], \n",
    "            torch.full_like(E_enrollment[patient_idx, :], enroll_time)\n",
    "        )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Person 0, Disease 294:\n",
      "  Event time: 20\n",
      "  Enrollment time: 24\n",
      "  Capped time: 20\n",
      "  OK: Event time before enrollment is unchanged.\n"
     ]
    }
   ],
   "source": [
    "for person_idx in range(E_100k.shape[0]):\n",
    "    enroll_time = int(pce_df_subset.iloc[person_idx]['age'] - 30)\n",
    "    for disease_idx in range(E_100k.shape[1]):\n",
    "        event_time = E_100k[person_idx, disease_idx].item()\n",
    "        if event_time < enroll_time:\n",
    "            capped_time = E_enrollment[person_idx, disease_idx].item()\n",
    "            print(f\"Person {person_idx}, Disease {disease_idx}:\")\n",
    "            print(f\"  Event time: {event_time}\")\n",
    "            print(f\"  Enrollment time: {enroll_time}\")\n",
    "            print(f\"  Capped time: {capped_time}\")\n",
    "            if capped_time != event_time:\n",
    "                print(\"  WARNING: Event time before enrollment was incorrectly capped!\")\n",
    "            else:\n",
    "                print(\"  OK: Event time before enrollment is unchanged.\")\n",
    "            break  # Stop after first found\n",
    "    else:\n",
    "        continue\n",
    "    break  # Stop after first found"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [],
   "source": [
    "\n",
    "G_with_sex = np.column_stack([G_100k, sex])  # sex should be numeric (e.g., 0/1)\n",
    "# N"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(10000, 37)"
      ]
     },
     "execution_count": 123,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "G_with_sex.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:76: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.signature_refs = torch.tensor(signature_references, dtype=torch.float32)\n",
      "/Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:88: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  self.Y = torch.tensor(Y, dtype=torch.float32)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Cluster Sizes:\n",
      "Cluster 0: 12 diseases\n",
      "Cluster 1: 29 diseases\n",
      "Cluster 2: 11 diseases\n",
      "Cluster 3: 12 diseases\n",
      "Cluster 4: 16 diseases\n",
      "Cluster 5: 7 diseases\n",
      "Cluster 6: 10 diseases\n",
      "Cluster 7: 6 diseases\n",
      "Cluster 8: 96 diseases\n",
      "Cluster 9: 14 diseases\n",
      "Cluster 10: 8 diseases\n",
      "Cluster 11: 7 diseases\n",
      "Cluster 12: 16 diseases\n",
      "Cluster 13: 36 diseases\n",
      "Cluster 14: 6 diseases\n",
      "Cluster 15: 8 diseases\n",
      "Cluster 16: 11 diseases\n",
      "Cluster 17: 27 diseases\n",
      "Cluster 18: 11 diseases\n",
      "Cluster 19: 5 diseases\n",
      "\n",
      "Calculating gamma for k=0:\n",
      "Number of diseases in cluster: 12\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.4783, -0.4783, -0.4783, -0.4783, -0.4783])\n",
      "Base value centered mean: -1.1146545375595451e-06\n",
      "Gamma init for k=0 (first 5): tensor([-0.0026, -0.0013, -0.0065,  0.0002, -0.0136])\n",
      "\n",
      "Calculating gamma for k=1:\n",
      "Number of diseases in cluster: 29\n",
      "Base value (first 5): tensor([-12.7931, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([ 0.9073, -0.1151, -0.1151, -0.1151, -0.1151])\n",
      "Base value centered mean: -3.386688149475958e-06\n",
      "Gamma init for k=1 (first 5): tensor([ 0.0050,  0.0010,  0.0018,  0.0017, -0.0005])\n",
      "\n",
      "Calculating gamma for k=2:\n",
      "Number of diseases in cluster: 11\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2724, -0.2724, -0.2724, -0.2724, -0.2724])\n",
      "Base value centered mean: -4.421234223173087e-07\n",
      "Gamma init for k=2 (first 5): tensor([-0.0112,  0.0054, -0.0058,  0.0070,  0.0123])\n",
      "\n",
      "Calculating gamma for k=3:\n",
      "Number of diseases in cluster: 12\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -12.9919])\n",
      "Base value centered (first 5): tensor([-0.2130, -0.2130, -0.2130, -0.2130,  0.6106])\n",
      "Base value centered mean: 5.474090585266822e-07\n",
      "Gamma init for k=3 (first 5): tensor([-0.0028, -0.0011,  0.0072, -0.0007,  0.0070])\n",
      "\n",
      "Calculating gamma for k=4:\n",
      "Number of diseases in cluster: 16\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1679, -0.1679, -0.1679, -0.1679, -0.1679])\n",
      "Base value centered mean: 7.253646572280559e-07\n",
      "Gamma init for k=4 (first 5): tensor([ 0.0010,  0.0030,  0.0049, -0.0013,  0.0339])\n",
      "\n",
      "Calculating gamma for k=5:\n",
      "Number of diseases in cluster: 7\n",
      "Base value (first 5): tensor([-13.8155, -12.4036, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.7193,  0.6927, -0.7193, -0.7193, -0.7193])\n",
      "Base value centered mean: -1.438140884602035e-06\n",
      "Gamma init for k=5 (first 5): tensor([-0.0029,  0.0034,  0.0177, -0.0053, -0.0029])\n",
      "\n",
      "Calculating gamma for k=6:\n",
      "Number of diseases in cluster: 10\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -12.8271])\n",
      "Base value centered (first 5): tensor([-0.1511, -0.1511, -0.1511, -0.1511,  0.8372])\n",
      "Base value centered mean: -1.5613555888194242e-06\n",
      "Gamma init for k=6 (first 5): tensor([-0.0104, -0.0039, -0.0025,  0.0004,  0.0043])\n",
      "\n",
      "Calculating gamma for k=7:\n",
      "Number of diseases in cluster: 6\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2473, -0.2473, -0.2473, -0.2473, -0.2473])\n",
      "Base value centered mean: -5.079269271845988e-07\n",
      "Gamma init for k=7 (first 5): tensor([-0.0139,  0.0088,  0.0022, -0.0099,  0.0074])\n",
      "\n",
      "Calculating gamma for k=8:\n",
      "Number of diseases in cluster: 96\n",
      "Base value (first 5): tensor([-13.6096, -13.8155, -13.8155, -13.8155, -13.6096])\n",
      "Base value centered (first 5): tensor([ 0.0845, -0.1214, -0.1214, -0.1214,  0.0845])\n",
      "Base value centered mean: -6.298064931797853e-07\n",
      "Gamma init for k=8 (first 5): tensor([-0.0012, -0.0007, -0.0022,  0.0015,  0.0016])\n",
      "\n",
      "Calculating gamma for k=9:\n",
      "Number of diseases in cluster: 14\n",
      "Base value (first 5): tensor([-13.8155, -12.4036, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1757,  1.2362, -0.1757, -0.1757, -0.1757])\n",
      "Base value centered mean: -1.6102791278171935e-06\n",
      "Gamma init for k=9 (first 5): tensor([-0.0029, -0.0014,  0.0002, -0.0020,  0.0042])\n",
      "\n",
      "Calculating gamma for k=10:\n",
      "Number of diseases in cluster: 8\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1478, -0.1478, -0.1478, -0.1478, -0.1478])\n",
      "Base value centered mean: -1.3303756531968247e-06\n",
      "Gamma init for k=10 (first 5): tensor([ 0.0200, -0.0095, -0.0044, -0.0005, -0.0014])\n",
      "\n",
      "Calculating gamma for k=11:\n",
      "Number of diseases in cluster: 7\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.0935, -0.0935, -0.0935, -0.0935, -0.0935])\n",
      "Base value centered mean: -2.1114349237905117e-06\n",
      "Gamma init for k=11 (first 5): tensor([0.0056, 0.0039, 0.0005, 0.0021, 0.0078])\n",
      "\n",
      "Calculating gamma for k=12:\n",
      "Number of diseases in cluster: 16\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.4285, -0.4285, -0.4285, -0.4285, -0.4285])\n",
      "Base value centered mean: -1.2178420547570568e-06\n",
      "Gamma init for k=12 (first 5): tensor([-0.0026, -0.0001, -0.0007,  0.0009,  0.0053])\n",
      "\n",
      "Calculating gamma for k=13:\n",
      "Number of diseases in cluster: 36\n",
      "Base value (first 5): tensor([-13.8155, -13.5410, -13.5410, -13.2664, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.4418, -0.1673, -0.1673,  0.1073, -0.4418])\n",
      "Base value centered mean: -9.565353309426428e-08\n",
      "Gamma init for k=13 (first 5): tensor([-0.0080, -0.0022,  0.0001,  0.0211,  0.0080])\n",
      "\n",
      "Calculating gamma for k=14:\n",
      "Number of diseases in cluster: 6\n",
      "Base value (first 5): tensor([-13.8155,  -8.8737, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1117,  4.8302, -0.1117, -0.1117, -0.1117])\n",
      "Base value centered mean: -1.5544891596164234e-07\n",
      "Gamma init for k=14 (first 5): tensor([0.0084, 0.0029, 0.0045, 0.0113, 0.0058])\n",
      "\n",
      "Calculating gamma for k=15:\n",
      "Number of diseases in cluster: 8\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2834, -0.2834, -0.2834, -0.2834, -0.2834])\n",
      "Base value centered mean: 4.6691894795003464e-07\n",
      "Gamma init for k=15 (first 5): tensor([-0.0036,  0.0225, -0.0092,  0.0169, -0.0109])\n",
      "\n",
      "Calculating gamma for k=16:\n",
      "Number of diseases in cluster: 11\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1309, -0.1309, -0.1309, -0.1309, -0.1309])\n",
      "Base value centered mean: -9.407043535247794e-07\n",
      "Gamma init for k=16 (first 5): tensor([-0.0061,  0.0006,  0.0002, -0.0002, -0.0004])\n",
      "\n",
      "Calculating gamma for k=17:\n",
      "Number of diseases in cluster: 27\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2835, -0.2835, -0.2835, -0.2835, -0.2835])\n",
      "Base value centered mean: -1.1606216503423639e-06\n",
      "Gamma init for k=17 (first 5): tensor([-0.0005,  0.0057,  0.0067,  0.0007,  0.0062])\n",
      "\n",
      "Calculating gamma for k=18:\n",
      "Number of diseases in cluster: 11\n",
      "Base value (first 5): tensor([-13.8155, -12.9170, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1553,  0.7433, -0.1553, -0.1553, -0.1553])\n",
      "Base value centered mean: 5.271911618365266e-07\n",
      "Gamma init for k=18 (first 5): tensor([-0.0018,  0.0050, -0.0033, -0.0008,  0.0015])\n",
      "\n",
      "Calculating gamma for k=19:\n",
      "Number of diseases in cluster: 5\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1214, -0.1214, -0.1214, -0.1214, -0.1214])\n",
      "Base value centered mean: -2.5482177079538815e-06\n",
      "Gamma init for k=19 (first 5): tensor([-0.0016, -0.0025, -0.0034,  0.0333, -0.0125])\n",
      "Initializing with 20 disease states + 1 healthy state\n",
      "Initialization complete!\n",
      "\n",
      "Calculating gamma for k=0:\n",
      "Number of diseases in cluster: 16.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1922, -0.1922, -0.1922, -0.1922, -0.1922])\n",
      "Base value centered mean: -4.0464399830852926e-07\n",
      "Gamma init for k=0 (first 5): tensor([0.0008, 0.0064, 0.0040, 0.0012, 0.0379])\n",
      "\n",
      "Calculating gamma for k=1:\n",
      "Number of diseases in cluster: 21.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -12.8742, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.3132, -0.3132, -0.3132,  0.6281, -0.3132])\n",
      "Base value centered mean: -8.939742883740109e-07\n",
      "Gamma init for k=1 (first 5): tensor([-6.3377e-03, -5.1546e-03,  5.0011e-03,  6.5982e-03, -3.5640e-05])\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/3075431586.py:29: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  initial_psi = torch.load('/Users/sarahurbut/Library/CloudStorage/Dropbox/data_for_running/initial_psi_400k.pt')\n",
      "/var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/3075431586.py:30: FutureWarning: You are using `torch.load` with `weights_only=False` (the current default value), which uses the default pickle module implicitly. It is possible to construct malicious pickle data which will execute arbitrary code during unpickling (See https://github.com/pytorch/pytorch/blob/main/SECURITY.md#untrusted-models for more details). In a future release, the default value for `weights_only` will be flipped to `True`. This limits the functions that could be executed during unpickling. Arbitrary objects will no longer be allowed to be loaded via this mode unless they are explicitly allowlisted by the user via `torch.serialization.add_safe_globals`. We recommend you start setting `weights_only=True` for any use case where you don't have full control of the loaded file. Please open an issue on GitHub for any issues related to this experimental feature.\n",
      "  initial_clusters = torch.load('/Users/sarahurbut/Library/CloudStorage/Dropbox/data_for_running/initial_clusters_400k.pt')\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Calculating gamma for k=2:\n",
      "Number of diseases in cluster: 15.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.3805, -0.3805, -0.3805, -0.3805, -0.3805])\n",
      "Base value centered mean: -1.216125497194298e-06\n",
      "Gamma init for k=2 (first 5): tensor([-0.0004,  0.0047, -0.0032, -0.0015, -0.0113])\n",
      "\n",
      "Calculating gamma for k=3:\n",
      "Number of diseases in cluster: 82.0\n",
      "Base value (first 5): tensor([-13.6950, -13.6950, -13.8155, -13.8155, -13.6950])\n",
      "Base value centered (first 5): tensor([ 0.0189,  0.0189, -0.1016, -0.1016,  0.0189])\n",
      "Base value centered mean: -8.369445936295961e-07\n",
      "Gamma init for k=3 (first 5): tensor([-0.0006, -0.0010, -0.0023,  0.0020,  0.0022])\n",
      "\n",
      "Calculating gamma for k=4:\n",
      "Number of diseases in cluster: 5.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1214, -0.1214, -0.1214, -0.1214, -0.1214])\n",
      "Base value centered mean: -2.5482177079538815e-06\n",
      "Gamma init for k=4 (first 5): tensor([-0.0016, -0.0025, -0.0034,  0.0333, -0.0125])\n",
      "\n",
      "Calculating gamma for k=5:\n",
      "Number of diseases in cluster: 7.0\n",
      "Base value (first 5): tensor([-13.8155, -12.4036, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.7193,  0.6927, -0.7193, -0.7193, -0.7193])\n",
      "Base value centered mean: -1.438140884602035e-06\n",
      "Gamma init for k=5 (first 5): tensor([-0.0029,  0.0034,  0.0177, -0.0053, -0.0029])\n",
      "\n",
      "Calculating gamma for k=6:\n",
      "Number of diseases in cluster: 8.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1478, -0.1478, -0.1478, -0.1478, -0.1478])\n",
      "Base value centered mean: -1.3303756531968247e-06\n",
      "Gamma init for k=6 (first 5): tensor([ 0.0200, -0.0095, -0.0044, -0.0005, -0.0014])\n",
      "\n",
      "Calculating gamma for k=7:\n",
      "Number of diseases in cluster: 22.0\n",
      "Base value (first 5): tensor([-13.8155, -13.3663, -13.3663, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.5468, -0.0975, -0.0975, -0.5468, -0.5468])\n",
      "Base value centered mean: 1.2176514019301976e-06\n",
      "Gamma init for k=7 (first 5): tensor([-0.0138, -0.0041, -0.0041,  0.0290,  0.0144])\n",
      "\n",
      "Calculating gamma for k=8:\n",
      "Number of diseases in cluster: 28.0\n",
      "Base value (first 5): tensor([-12.7565, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([ 0.9411, -0.1179, -0.1179, -0.1179, -0.1179])\n",
      "Base value centered mean: -7.065772820169514e-07\n",
      "Gamma init for k=8 (first 5): tensor([ 0.0051,  0.0011,  0.0015,  0.0017, -0.0005])\n",
      "\n",
      "Calculating gamma for k=9:\n",
      "Number of diseases in cluster: 12.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -12.9919])\n",
      "Base value centered (first 5): tensor([-0.2011, -0.2011, -0.2011, -0.2011,  0.6226])\n",
      "Base value centered mean: -3.2243727332570415e-07\n",
      "Gamma init for k=9 (first 5): tensor([-0.0041, -0.0013,  0.0037, -0.0024,  0.0054])\n",
      "\n",
      "Calculating gamma for k=10:\n",
      "Number of diseases in cluster: 11.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2724, -0.2724, -0.2724, -0.2724, -0.2724])\n",
      "Base value centered mean: -4.421234223173087e-07\n",
      "Gamma init for k=10 (first 5): tensor([-0.0112,  0.0054, -0.0058,  0.0070,  0.0123])\n",
      "\n",
      "Calculating gamma for k=11:\n",
      "Number of diseases in cluster: 8.0\n",
      "Base value (first 5): tensor([-13.8155, -10.1091, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1143,  3.5921, -0.1143, -0.1143, -0.1143])\n",
      "Base value centered mean: -1.6385077969971462e-06\n",
      "Gamma init for k=11 (first 5): tensor([-0.0006,  0.0028,  0.0070,  0.0099,  0.0037])\n",
      "\n",
      "Calculating gamma for k=12:\n",
      "Number of diseases in cluster: 7.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.0935, -0.0935, -0.0935, -0.0935, -0.0935])\n",
      "Base value centered mean: -2.1114349237905117e-06\n",
      "Gamma init for k=12 (first 5): tensor([0.0056, 0.0039, 0.0005, 0.0021, 0.0078])\n",
      "\n",
      "Calculating gamma for k=13:\n",
      "Number of diseases in cluster: 13.0\n",
      "Base value (first 5): tensor([-13.8155, -12.2949, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.1847,  1.3359, -0.1847, -0.1847, -0.1847])\n",
      "Base value centered mean: 3.030776838386373e-07\n",
      "Gamma init for k=13 (first 5): tensor([-1.8910e-03, -2.2000e-03, -3.9552e-05, -2.5409e-03,  5.4868e-03])\n",
      "\n",
      "Calculating gamma for k=14:\n",
      "Number of diseases in cluster: 10.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2649, -0.2649, -0.2649, -0.2649, -0.2649])\n",
      "Base value centered mean: -1.3841629424860002e-06\n",
      "Gamma init for k=14 (first 5): tensor([-0.0048,  0.0167, -0.0074,  0.0148, -0.0078])\n",
      "\n",
      "Calculating gamma for k=15:\n",
      "Number of diseases in cluster: 5.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2876, -0.2876, -0.2876, -0.2876, -0.2876])\n",
      "Base value centered mean: -1.691532133918372e-06\n",
      "Gamma init for k=15 (first 5): tensor([-0.0168,  0.0080,  0.0006, -0.0095,  0.0071])\n",
      "\n",
      "Calculating gamma for k=16:\n",
      "Number of diseases in cluster: 29.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.2418, -0.2418, -0.2418, -0.2418, -0.2418])\n",
      "Base value centered mean: -3.061580628127558e-06\n",
      "Gamma init for k=16 (first 5): tensor([-0.0023,  0.0051,  0.0082,  0.0018,  0.0012])\n",
      "\n",
      "Calculating gamma for k=17:\n",
      "Number of diseases in cluster: 17.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -13.8155])\n",
      "Base value centered (first 5): tensor([-0.4125, -0.4125, -0.4125, -0.4125, -0.4125])\n",
      "Base value centered mean: -8.33702074487519e-07\n",
      "Gamma init for k=17 (first 5): tensor([-0.0025,  0.0001,  0.0003,  0.0010,  0.0047])\n",
      "\n",
      "Calculating gamma for k=18:\n",
      "Number of diseases in cluster: 9.0\n",
      "Base value (first 5): tensor([-13.8155, -13.8155, -13.8155, -13.8155, -12.7173])\n",
      "Base value centered (first 5): tensor([-0.1498, -0.1498, -0.1498, -0.1498,  0.9484])\n",
      "Base value centered mean: -6.093979010302064e-08\n",
      "Gamma init for k=18 (first 5): tensor([-0.0112, -0.0042, -0.0028,  0.0023,  0.0065])\n",
      "\n",
      "Calculating gamma for k=19:\n",
      "Number of diseases in cluster: 23.0\n",
      "Base value (first 5): tensor([-13.3858, -13.8155, -13.8155, -13.8155, -13.3858])\n",
      "Base value centered (first 5): tensor([ 0.2681, -0.1617, -0.1617, -0.1617,  0.2681])\n",
      "Base value centered mean: -1.4364242133524385e-06\n",
      "Gamma init for k=19 (first 5): tensor([ 0.0042,  0.0039, -0.0052, -0.0055,  0.0015])\n",
      "Initializing with 20 disease states + 1 healthy state\n",
      "Initialization complete!\n",
      "\n",
      "Clusters match exactly: True\n"
     ]
    }
   ],
   "source": [
    "\n",
    "\n",
    "model = AladynSurvivalFixedKernelsAvgLoss_clust_logitInit_psitest(\n",
    "    N=Y_100k.shape[0], \n",
    "    D=Y_100k.shape[1], \n",
    "    T=Y_100k.shape[2], \n",
    "    K=20,\n",
    "    P=G_with_sex.shape[1],\n",
    "    init_sd_scaler=1e-1,\n",
    "    G=G_with_sex, \n",
    "    Y=Y_100k,\n",
    "    genetic_scale=1,\n",
    "    W=0.0001,\n",
    "    R=0,\n",
    "    prevalence_t=essentials['prevalence_t'],\n",
    "    signature_references=signature_refs,  # Only pass signature refs\n",
    "    healthy_reference=True,  # Explicitly set to None\n",
    "    disease_names=essentials['disease_names']\n",
    ")\n",
    "\n",
    "torch.manual_seed(0)\n",
    "np.random.seed(0)\n",
    "# Initialize with psi and clusters\n",
    "\n",
    "\n",
    "import cProfile\n",
    "import pstats\n",
    "from pstats import SortKey\n",
    "\n",
    "# Now in your batch run, load and verify:\n",
    "initial_psi = torch.load('/Users/sarahurbut/Library/CloudStorage/Dropbox/data_for_running/initial_psi_400k.pt')\n",
    "initial_clusters = torch.load('/Users/sarahurbut/Library/CloudStorage/Dropbox/data_for_running/initial_clusters_400k.pt')\n",
    "\n",
    "model.initialize_params(true_psi=initial_psi)\n",
    "model.clusters = initial_clusters\n",
    "# Verify clusters match\n",
    "clusters_match = np.array_equal(initial_clusters, model.clusters)\n",
    "print(f\"\\nClusters match exactly: {clusters_match}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "torch.Size([10000, 37])\n",
      "torch.Size([37, 21])\n"
     ]
    }
   ],
   "source": [
    "print(model.G.shape)\n",
    "print(model.gamma.shape)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Fit the model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:238: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  event_times_tensor = torch.tensor(event_times, dtype=torch.long)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Epoch 0\n",
      "Loss: 16.9486\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=32.01):\n",
      "  Theta for diagnosed: 0.150 ± 0.038\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.74):\n",
      "  Theta for diagnosed: 0.151 ± 0.039\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.42):\n",
      "  Theta for diagnosed: 0.098 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.148 ± 0.071\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 1\n",
      "Loss: 663.8109\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=32.00):\n",
      "  Theta for diagnosed: 0.150 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.76):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.45):\n",
      "  Theta for diagnosed: 0.098 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.84):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 2\n",
      "Loss: 68.8834\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=32.00):\n",
      "  Theta for diagnosed: 0.150 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.79):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.49):\n",
      "  Theta for diagnosed: 0.098 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.44):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.83):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 3\n",
      "Loss: 164.1191\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.99):\n",
      "  Theta for diagnosed: 0.150 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.79):\n",
      "  Theta for diagnosed: 0.152 ± 0.038\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.51):\n",
      "  Theta for diagnosed: 0.098 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.83):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 4\n",
      "Loss: 379.2064\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.95):\n",
      "  Theta for diagnosed: 0.150 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.78):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.51):\n",
      "  Theta for diagnosed: 0.098 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.84):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 5\n",
      "Loss: 287.0578\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.90):\n",
      "  Theta for diagnosed: 0.150 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.76):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.50):\n",
      "  Theta for diagnosed: 0.098 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.85):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 6\n",
      "Loss: 102.0201\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.84):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.74):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.49):\n",
      "  Theta for diagnosed: 0.098 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.148 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 7\n",
      "Loss: 33.1505\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.77):\n",
      "  Theta for diagnosed: 0.150 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.72):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.48):\n",
      "  Theta for diagnosed: 0.098 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.45):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 8\n",
      "Loss: 103.9936\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.69):\n",
      "  Theta for diagnosed: 0.150 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.70):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.48):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 9\n",
      "Loss: 185.4497\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.60):\n",
      "  Theta for diagnosed: 0.150 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.69):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.49):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 10\n",
      "Loss: 175.8441\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.51):\n",
      "  Theta for diagnosed: 0.151 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.68):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.50):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.48):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 11\n",
      "Loss: 99.1981\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.41):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.67):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.52):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.49):\n",
      "  Theta for diagnosed: 0.148 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 12\n",
      "Loss: 35.7737\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.30):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.66):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.50):\n",
      "  Theta for diagnosed: 0.148 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.86):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 13\n",
      "Loss: 34.0976\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.19):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.65):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.148 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.85):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 14\n",
      "Loss: 76.2634\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=31.07):\n",
      "  Theta for diagnosed: 0.151 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.63):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.85):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 15\n",
      "Loss: 107.1291\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=30.95):\n",
      "  Theta for diagnosed: 0.151 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.60):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.148 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.85):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 16\n",
      "Loss: 94.9718\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=30.82):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 76 (signature 7, LR=30.57):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.148 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 114 (signature 5, LR=28.91):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Epoch 17\n",
      "Loss: 55.7617\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=30.69):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.54):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.148 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 114 (signature 5, LR=29.00):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Epoch 18\n",
      "Loss: 26.6788\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 161 (signature 7, LR=30.55):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.51):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 114 (signature 5, LR=29.09):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Epoch 19\n",
      "Loss: 28.5380\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.099 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.47):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 161 (signature 7, LR=30.41):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 114 (signature 5, LR=29.18):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Epoch 20\n",
      "Loss: 50.1920\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.100 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.44):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 161 (signature 7, LR=30.27):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 114 (signature 5, LR=29.27):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Epoch 21\n",
      "Loss: 64.3608\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.100 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.42):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 161 (signature 7, LR=30.12):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 114 (signature 5, LR=29.36):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Epoch 22\n",
      "Loss: 56.4965\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.100 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.39):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 161 (signature 7, LR=29.97):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 114 (signature 5, LR=29.45):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Epoch 23\n",
      "Loss: 35.9547\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.36):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 161 (signature 7, LR=29.82):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 114 (signature 5, LR=29.54):\n",
      "  Theta for diagnosed: 0.062 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.53):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Epoch 24\n",
      "Loss: 22.3327\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 76 (signature 7, LR=30.33):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 161 (signature 7, LR=29.67):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Disease 114 (signature 5, LR=29.63):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.53):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Epoch 25\n",
      "Loss: 25.2388\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 76 (signature 7, LR=30.29):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 114 (signature 5, LR=29.71):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.53):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 161 (signature 7, LR=29.52):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 26\n",
      "Loss: 36.8790\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 76 (signature 7, LR=30.25):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 114 (signature 5, LR=29.80):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.53):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 161 (signature 7, LR=29.36):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 27\n",
      "Loss: 42.5003\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 76 (signature 7, LR=30.21):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 114 (signature 5, LR=29.89):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.53):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 161 (signature 7, LR=29.21):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 28\n",
      "Loss: 36.1383\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 76 (signature 7, LR=30.17):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 114 (signature 5, LR=29.98):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 161 (signature 7, LR=29.05):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 29\n",
      "Loss: 24.9027\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 76 (signature 7, LR=30.12):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 114 (signature 5, LR=30.06):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 161 (signature 7, LR=28.89):\n",
      "  Theta for diagnosed: 0.151 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.003\n",
      "\n",
      "Epoch 30\n",
      "Loss: 19.5704\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 114 (signature 5, LR=30.15):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 76 (signature 7, LR=30.08):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.52):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 31\n",
      "Loss: 23.2376\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 114 (signature 5, LR=30.24):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 76 (signature 7, LR=30.04):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 32\n",
      "Loss: 29.4380\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 114 (signature 5, LR=30.32):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 76 (signature 7, LR=29.99):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 33\n",
      "Loss: 30.3434\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 114 (signature 5, LR=30.41):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 76 (signature 7, LR=29.95):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 34\n",
      "Loss: 25.0968\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 114 (signature 5, LR=30.50):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 76 (signature 7, LR=29.91):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 35\n",
      "Loss: 19.4818\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=30.59):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 76 (signature 7, LR=29.87):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 36\n",
      "Loss: 18.7133\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=30.68):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 76 (signature 7, LR=29.82):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 37\n",
      "Loss: 22.0122\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=30.76):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 76 (signature 7, LR=29.78):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.51):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 38\n",
      "Loss: 24.4290\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=30.85):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 76 (signature 7, LR=29.73):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.50):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.87):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 39\n",
      "Loss: 22.9154\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=30.94):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 76 (signature 7, LR=29.68):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.50):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 40\n",
      "Loss: 19.3310\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.03):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 76 (signature 7, LR=29.63):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.148\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.49):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 41\n",
      "Loss: 17.5406\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.13):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 76 (signature 7, LR=29.58):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.49):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 42\n",
      "Loss: 18.7677\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.22):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 76 (signature 7, LR=29.53):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.49):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 43\n",
      "Loss: 20.6559\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.32):\n",
      "  Theta for diagnosed: 0.062 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 76 (signature 7, LR=29.49):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 347 (signature 3, LR=29.48):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 44\n",
      "Loss: 20.5497\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.41):\n",
      "  Theta for diagnosed: 0.063 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.48):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=29.44):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 45\n",
      "Loss: 18.5951\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.51):\n",
      "  Theta for diagnosed: 0.063 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.48):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=29.39):\n",
      "  Theta for diagnosed: 0.152 ± 0.036\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 46\n",
      "Loss: 17.0875\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.61):\n",
      "  Theta for diagnosed: 0.063 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.48):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=29.35):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.88):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 47\n",
      "Loss: 17.4226\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.70):\n",
      "  Theta for diagnosed: 0.063 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.47):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=29.30):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 48\n",
      "Loss: 18.5998\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.80):\n",
      "  Theta for diagnosed: 0.063 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.47):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=29.25):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 49\n",
      "Loss: 18.8163\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=31.91):\n",
      "  Theta for diagnosed: 0.063 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=29.20):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 50\n",
      "Loss: 17.7676\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.01):\n",
      "  Theta for diagnosed: 0.063 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=29.15):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 51\n",
      "Loss: 16.7573\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.11):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=29.10):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 52\n",
      "Loss: 16.8286\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.22):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.104 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.46):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=29.05):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 53\n",
      "Loss: 17.5230\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.33):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.104 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 347 (signature 3, LR=29.45):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=29.01):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 54\n",
      "Loss: 17.7044\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.44):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.104 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 347 (signature 3, LR=29.45):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=28.96):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 55\n",
      "Loss: 17.0978\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.55):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.104 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 347 (signature 3, LR=29.45):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 76 (signature 7, LR=28.91):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 56\n",
      "Loss: 16.4858\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.66):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.104 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 347 (signature 3, LR=29.45):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.89):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=28.87):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 57\n",
      "Loss: 16.5297\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.78):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.104 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 347 (signature 3, LR=29.44):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.90):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=28.82):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 58\n",
      "Loss: 16.9409\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=32.89):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.52):\n",
      "  Theta for diagnosed: 0.105 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 347 (signature 3, LR=29.44):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.90):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=28.77):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 59\n",
      "Loss: 17.0172\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.01):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.52):\n",
      "  Theta for diagnosed: 0.105 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 347 (signature 3, LR=29.44):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.90):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=28.72):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 60\n",
      "Loss: 16.6280\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.12):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.52):\n",
      "  Theta for diagnosed: 0.105 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 347 (signature 3, LR=29.44):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.90):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=28.68):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 61\n",
      "Loss: 16.2862\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.24):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.105 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 347 (signature 3, LR=29.44):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.90):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=28.63):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 62\n",
      "Loss: 16.3574\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.36):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.105 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 347 (signature 3, LR=29.43):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.90):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 76 (signature 7, LR=28.58):\n",
      "  Theta for diagnosed: 0.152 ± 0.037\n",
      "  Theta for others: 0.147\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 63\n",
      "Loss: 16.5979\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.49):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.106 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 347 (signature 3, LR=29.43):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.90):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.56):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 64\n",
      "Loss: 16.5863\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.61):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.106 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 347 (signature 3, LR=29.43):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.91):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.56):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 65\n",
      "Loss: 16.3237\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.73):\n",
      "  Theta for diagnosed: 0.063 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.106 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 347 (signature 3, LR=29.43):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.91):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.57):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 66\n",
      "Loss: 16.1579\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.85):\n",
      "  Theta for diagnosed: 0.063 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.106 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 347 (signature 3, LR=29.43):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.91):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.58):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 67\n",
      "Loss: 16.2463\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=33.98):\n",
      "  Theta for diagnosed: 0.063 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.106 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 347 (signature 3, LR=29.43):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.91):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.59):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 68\n",
      "Loss: 16.3712\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=34.11):\n",
      "  Theta for diagnosed: 0.063 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.106 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 347 (signature 3, LR=29.43):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.91):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.60):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 69\n",
      "Loss: 16.3073\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=34.23):\n",
      "  Theta for diagnosed: 0.063 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.107 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.91):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.61):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 70\n",
      "Loss: 16.1376\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=34.36):\n",
      "  Theta for diagnosed: 0.064 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.53):\n",
      "  Theta for diagnosed: 0.107 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.91):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.61):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 71\n",
      "Loss: 16.0824\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=34.49):\n",
      "  Theta for diagnosed: 0.064 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.107 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.92):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.62):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 72\n",
      "Loss: 16.1629\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=34.62):\n",
      "  Theta for diagnosed: 0.064 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.107 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.92):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.63):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 73\n",
      "Loss: 16.2057\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=34.74):\n",
      "  Theta for diagnosed: 0.064 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.107 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.92):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 246 (signature 13, LR=28.64):\n",
      "  Theta for diagnosed: 0.025 ± 0.007\n",
      "  Theta for others: 0.023\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 74\n",
      "Loss: 16.1250\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=34.87):\n",
      "  Theta for diagnosed: 0.064 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.108 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.92):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 269 (signature 8, LR=28.69):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 75\n",
      "Loss: 16.0314\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.00):\n",
      "  Theta for diagnosed: 0.064 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.108 ± 0.096\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.92):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 269 (signature 8, LR=28.76):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 76\n",
      "Loss: 16.0360\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.13):\n",
      "  Theta for diagnosed: 0.064 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.108 ± 0.096\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 347 (signature 3, LR=29.42):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.92):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 269 (signature 8, LR=28.83):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 77\n",
      "Loss: 16.0884\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.26):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.108 ± 0.096\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.93):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Disease 269 (signature 8, LR=28.91):\n",
      "  Theta for diagnosed: 0.100 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 78\n",
      "Loss: 16.0784\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.39):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.109 ± 0.097\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 269 (signature 8, LR=28.98):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 50 (signature 15, LR=28.93):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 79\n",
      "Loss: 16.0097\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.52):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.109 ± 0.097\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 269 (signature 8, LR=29.06):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 50 (signature 15, LR=28.93):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 80\n",
      "Loss: 15.9740\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.65):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.109 ± 0.098\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 269 (signature 8, LR=29.14):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 50 (signature 15, LR=28.93):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 81\n",
      "Loss: 15.9983\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.78):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.109 ± 0.098\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 269 (signature 8, LR=29.21):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 50 (signature 15, LR=28.93):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 82\n",
      "Loss: 16.0156\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=35.91):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.109 ± 0.098\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 269 (signature 8, LR=29.29):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 50 (signature 15, LR=28.93):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 83\n",
      "Loss: 15.9826\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.04):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.55):\n",
      "  Theta for diagnosed: 0.110 ± 0.099\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 269 (signature 8, LR=29.37):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 50 (signature 15, LR=28.93):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 84\n",
      "Loss: 15.9413\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.16):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.110 ± 0.099\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 269 (signature 8, LR=29.45):\n",
      "  Theta for diagnosed: 0.101 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 347 (signature 3, LR=29.41):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.94):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 85\n",
      "Loss: 15.9396\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.29):\n",
      "  Theta for diagnosed: 0.064 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.110 ± 0.100\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 269 (signature 8, LR=29.53):\n",
      "  Theta for diagnosed: 0.101 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 347 (signature 3, LR=29.40):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.94):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 86\n",
      "Loss: 15.9567\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.42):\n",
      "  Theta for diagnosed: 0.064 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.110 ± 0.100\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 269 (signature 8, LR=29.61):\n",
      "  Theta for diagnosed: 0.101 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 347 (signature 3, LR=29.40):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.94):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 87\n",
      "Loss: 15.9470\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.55):\n",
      "  Theta for diagnosed: 0.064 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.111 ± 0.100\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 269 (signature 8, LR=29.69):\n",
      "  Theta for diagnosed: 0.101 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 347 (signature 3, LR=29.40):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 50 (signature 15, LR=28.94):\n",
      "  Theta for diagnosed: 0.016 ± 0.006\n",
      "  Theta for others: 0.014\n",
      "  Proportion difference: 0.002\n",
      "\n",
      "Epoch 88\n",
      "Loss: 15.9156\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.68):\n",
      "  Theta for diagnosed: 0.064 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.111 ± 0.101\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 269 (signature 8, LR=29.77):\n",
      "  Theta for diagnosed: 0.101 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 347 (signature 3, LR=29.40):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=28.96):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 89\n",
      "Loss: 15.9011\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.81):\n",
      "  Theta for diagnosed: 0.064 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.56):\n",
      "  Theta for diagnosed: 0.111 ± 0.101\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 269 (signature 8, LR=29.85):\n",
      "  Theta for diagnosed: 0.102 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 347 (signature 3, LR=29.40):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=28.98):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 90\n",
      "Loss: 15.9090\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=36.93):\n",
      "  Theta for diagnosed: 0.065 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.57):\n",
      "  Theta for diagnosed: 0.111 ± 0.102\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 269 (signature 8, LR=29.94):\n",
      "  Theta for diagnosed: 0.102 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 347 (signature 3, LR=29.40):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=29.01):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 91\n",
      "Loss: 15.9090\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.06):\n",
      "  Theta for diagnosed: 0.065 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 260 (signature 8, LR=30.57):\n",
      "  Theta for diagnosed: 0.111 ± 0.102\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 269 (signature 8, LR=30.02):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=29.03):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 92\n",
      "Loss: 15.8892\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.19):\n",
      "  Theta for diagnosed: 0.065 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 260 (signature 8, LR=30.57):\n",
      "  Theta for diagnosed: 0.112 ± 0.103\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 269 (signature 8, LR=30.10):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=29.06):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 93\n",
      "Loss: 15.8718\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.31):\n",
      "  Theta for diagnosed: 0.065 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 260 (signature 8, LR=30.57):\n",
      "  Theta for diagnosed: 0.112 ± 0.103\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 269 (signature 8, LR=30.19):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.149 ± 0.069\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=29.08):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 94\n",
      "Loss: 15.8715\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.44):\n",
      "  Theta for diagnosed: 0.065 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 260 (signature 8, LR=30.57):\n",
      "  Theta for diagnosed: 0.112 ± 0.104\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=30.27):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=29.11):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 95\n",
      "Loss: 15.8731\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.56):\n",
      "  Theta for diagnosed: 0.065 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 260 (signature 8, LR=30.58):\n",
      "  Theta for diagnosed: 0.112 ± 0.104\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=30.36):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 336 (signature 9, LR=29.14):\n",
      "  Theta for diagnosed: 0.031 ± 0.005\n",
      "  Theta for others: 0.030\n",
      "  Proportion difference: 0.001\n",
      "\n",
      "Epoch 96\n",
      "Loss: 15.8614\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.69):\n",
      "  Theta for diagnosed: 0.065 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 260 (signature 8, LR=30.58):\n",
      "  Theta for diagnosed: 0.113 ± 0.104\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=30.45):\n",
      "  Theta for diagnosed: 0.102 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 52 (signature 5, LR=29.19):\n",
      "  Theta for diagnosed: 0.056 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 97\n",
      "Loss: 15.8458\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.81):\n",
      "  Theta for diagnosed: 0.065 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 260 (signature 8, LR=30.58):\n",
      "  Theta for diagnosed: 0.113 ± 0.105\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=30.54):\n",
      "  Theta for diagnosed: 0.102 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 347 (signature 3, LR=29.39):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 52 (signature 5, LR=29.26):\n",
      "  Theta for diagnosed: 0.056 ± 0.040\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 98\n",
      "Loss: 15.8405\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=37.94):\n",
      "  Theta for diagnosed: 0.065 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=30.62):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 260 (signature 8, LR=30.58):\n",
      "  Theta for diagnosed: 0.113 ± 0.105\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 347 (signature 3, LR=29.38):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Disease 52 (signature 5, LR=29.33):\n",
      "  Theta for diagnosed: 0.056 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 99\n",
      "Loss: 15.8406\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.06):\n",
      "  Theta for diagnosed: 0.065 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=30.71):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 260 (signature 8, LR=30.58):\n",
      "  Theta for diagnosed: 0.113 ± 0.106\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 52 (signature 5, LR=29.40):\n",
      "  Theta for diagnosed: 0.056 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.38):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Epoch 100\n",
      "Loss: 15.8332\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.19):\n",
      "  Theta for diagnosed: 0.065 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=30.80):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 260 (signature 8, LR=30.59):\n",
      "  Theta for diagnosed: 0.114 ± 0.106\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 52 (signature 5, LR=29.47):\n",
      "  Theta for diagnosed: 0.056 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.38):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Epoch 101\n",
      "Loss: 15.8204\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.31):\n",
      "  Theta for diagnosed: 0.065 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=30.89):\n",
      "  Theta for diagnosed: 0.103 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.59):\n",
      "  Theta for diagnosed: 0.114 ± 0.107\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 52 (signature 5, LR=29.54):\n",
      "  Theta for diagnosed: 0.057 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 347 (signature 3, LR=29.38):\n",
      "  Theta for diagnosed: 0.149 ± 0.070\n",
      "  Theta for others: 0.150\n",
      "  Proportion difference: -0.001\n",
      "\n",
      "Epoch 102\n",
      "Loss: 15.8130\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.44):\n",
      "  Theta for diagnosed: 0.065 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=30.99):\n",
      "  Theta for diagnosed: 0.103 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.59):\n",
      "  Theta for diagnosed: 0.114 ± 0.107\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 52 (signature 5, LR=29.61):\n",
      "  Theta for diagnosed: 0.057 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 281 (signature 8, LR=29.48):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 103\n",
      "Loss: 15.8110\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.56):\n",
      "  Theta for diagnosed: 0.065 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=31.08):\n",
      "  Theta for diagnosed: 0.103 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.59):\n",
      "  Theta for diagnosed: 0.114 ± 0.108\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 281 (signature 8, LR=29.68):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 52 (signature 5, LR=29.67):\n",
      "  Theta for diagnosed: 0.057 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 104\n",
      "Loss: 15.8054\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.68):\n",
      "  Theta for diagnosed: 0.065 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=31.17):\n",
      "  Theta for diagnosed: 0.103 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.60):\n",
      "  Theta for diagnosed: 0.114 ± 0.108\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 281 (signature 8, LR=29.88):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 52 (signature 5, LR=29.74):\n",
      "  Theta for diagnosed: 0.057 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 105\n",
      "Loss: 15.7951\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.81):\n",
      "  Theta for diagnosed: 0.065 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=31.27):\n",
      "  Theta for diagnosed: 0.103 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.60):\n",
      "  Theta for diagnosed: 0.115 ± 0.109\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 281 (signature 8, LR=30.08):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 52 (signature 5, LR=29.81):\n",
      "  Theta for diagnosed: 0.057 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 106\n",
      "Loss: 15.7872\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=38.93):\n",
      "  Theta for diagnosed: 0.066 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=31.36):\n",
      "  Theta for diagnosed: 0.103 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.60):\n",
      "  Theta for diagnosed: 0.115 ± 0.109\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 281 (signature 8, LR=30.28):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 52 (signature 5, LR=29.87):\n",
      "  Theta for diagnosed: 0.057 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 107\n",
      "Loss: 15.7835\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.05):\n",
      "  Theta for diagnosed: 0.066 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=31.46):\n",
      "  Theta for diagnosed: 0.104 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 260 (signature 8, LR=30.60):\n",
      "  Theta for diagnosed: 0.115 ± 0.110\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 281 (signature 8, LR=30.49):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 52 (signature 5, LR=29.94):\n",
      "  Theta for diagnosed: 0.057 ± 0.041\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 108\n",
      "Loss: 15.7784\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.17):\n",
      "  Theta for diagnosed: 0.066 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=31.55):\n",
      "  Theta for diagnosed: 0.104 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 281 (signature 8, LR=30.69):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 260 (signature 8, LR=30.61):\n",
      "  Theta for diagnosed: 0.115 ± 0.110\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 52 (signature 5, LR=30.00):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 109\n",
      "Loss: 15.7697\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.29):\n",
      "  Theta for diagnosed: 0.066 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=31.65):\n",
      "  Theta for diagnosed: 0.104 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 281 (signature 8, LR=30.90):\n",
      "  Theta for diagnosed: 0.100 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 260 (signature 8, LR=30.61):\n",
      "  Theta for diagnosed: 0.116 ± 0.111\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 52 (signature 5, LR=30.07):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 110\n",
      "Loss: 15.7620\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.42):\n",
      "  Theta for diagnosed: 0.066 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=31.75):\n",
      "  Theta for diagnosed: 0.104 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 281 (signature 8, LR=31.11):\n",
      "  Theta for diagnosed: 0.101 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 260 (signature 8, LR=30.61):\n",
      "  Theta for diagnosed: 0.116 ± 0.111\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 52 (signature 5, LR=30.13):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 111\n",
      "Loss: 15.7572\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.54):\n",
      "  Theta for diagnosed: 0.066 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=31.84):\n",
      "  Theta for diagnosed: 0.104 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 281 (signature 8, LR=31.32):\n",
      "  Theta for diagnosed: 0.101 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 260 (signature 8, LR=30.62):\n",
      "  Theta for diagnosed: 0.116 ± 0.112\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 52 (signature 5, LR=30.20):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 112\n",
      "Loss: 15.7521\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.66):\n",
      "  Theta for diagnosed: 0.066 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=31.94):\n",
      "  Theta for diagnosed: 0.104 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 281 (signature 8, LR=31.53):\n",
      "  Theta for diagnosed: 0.101 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 260 (signature 8, LR=30.62):\n",
      "  Theta for diagnosed: 0.116 ± 0.112\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 52 (signature 5, LR=30.26):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 113\n",
      "Loss: 15.7444\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.78):\n",
      "  Theta for diagnosed: 0.066 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=32.04):\n",
      "  Theta for diagnosed: 0.104 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 281 (signature 8, LR=31.74):\n",
      "  Theta for diagnosed: 0.101 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Disease 260 (signature 8, LR=30.62):\n",
      "  Theta for diagnosed: 0.117 ± 0.113\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 52 (signature 5, LR=30.33):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 114\n",
      "Loss: 15.7370\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=39.90):\n",
      "  Theta for diagnosed: 0.066 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=32.15):\n",
      "  Theta for diagnosed: 0.104 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 281 (signature 8, LR=31.96):\n",
      "  Theta for diagnosed: 0.101 ± 0.082\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 260 (signature 8, LR=30.62):\n",
      "  Theta for diagnosed: 0.117 ± 0.113\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 52 (signature 5, LR=30.39):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 115\n",
      "Loss: 15.7316\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.02):\n",
      "  Theta for diagnosed: 0.066 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 269 (signature 8, LR=32.25):\n",
      "  Theta for diagnosed: 0.104 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 281 (signature 8, LR=32.17):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 260 (signature 8, LR=30.63):\n",
      "  Theta for diagnosed: 0.117 ± 0.114\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.030\n",
      "\n",
      "Disease 52 (signature 5, LR=30.46):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 116\n",
      "Loss: 15.7262\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.14):\n",
      "  Theta for diagnosed: 0.066 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 281 (signature 8, LR=32.39):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=32.35):\n",
      "  Theta for diagnosed: 0.105 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.63):\n",
      "  Theta for diagnosed: 0.117 ± 0.114\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.030\n",
      "\n",
      "Disease 52 (signature 5, LR=30.52):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 117\n",
      "Loss: 15.7191\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.25):\n",
      "  Theta for diagnosed: 0.066 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 281 (signature 8, LR=32.61):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=32.45):\n",
      "  Theta for diagnosed: 0.105 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 260 (signature 8, LR=30.63):\n",
      "  Theta for diagnosed: 0.118 ± 0.115\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.030\n",
      "\n",
      "Disease 52 (signature 5, LR=30.59):\n",
      "  Theta for diagnosed: 0.057 ± 0.042\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Epoch 118\n",
      "Loss: 15.7120\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.37):\n",
      "  Theta for diagnosed: 0.066 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 281 (signature 8, LR=32.83):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=32.56):\n",
      "  Theta for diagnosed: 0.105 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=30.65):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.64):\n",
      "  Theta for diagnosed: 0.118 ± 0.115\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.030\n",
      "\n",
      "Epoch 119\n",
      "Loss: 15.7063\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.49):\n",
      "  Theta for diagnosed: 0.066 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 281 (signature 8, LR=33.05):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=32.66):\n",
      "  Theta for diagnosed: 0.105 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=30.71):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.64):\n",
      "  Theta for diagnosed: 0.118 ± 0.116\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.031\n",
      "\n",
      "Epoch 120\n",
      "Loss: 15.7007\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.61):\n",
      "  Theta for diagnosed: 0.067 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 281 (signature 8, LR=33.28):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=32.76):\n",
      "  Theta for diagnosed: 0.105 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=30.78):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.64):\n",
      "  Theta for diagnosed: 0.118 ± 0.116\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.031\n",
      "\n",
      "Epoch 121\n",
      "Loss: 15.6940\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.72):\n",
      "  Theta for diagnosed: 0.067 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=33.50):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=32.87):\n",
      "  Theta for diagnosed: 0.105 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=30.84):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.65):\n",
      "  Theta for diagnosed: 0.119 ± 0.117\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.031\n",
      "\n",
      "Epoch 122\n",
      "Loss: 15.6872\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.84):\n",
      "  Theta for diagnosed: 0.067 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=33.73):\n",
      "  Theta for diagnosed: 0.101 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=32.98):\n",
      "  Theta for diagnosed: 0.105 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=30.91):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.65):\n",
      "  Theta for diagnosed: 0.119 ± 0.117\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.031\n",
      "\n",
      "Epoch 123\n",
      "Loss: 15.6813\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=40.95):\n",
      "  Theta for diagnosed: 0.067 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=33.96):\n",
      "  Theta for diagnosed: 0.102 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=33.08):\n",
      "  Theta for diagnosed: 0.105 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=30.97):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.66):\n",
      "  Theta for diagnosed: 0.119 ± 0.118\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.032\n",
      "\n",
      "Epoch 124\n",
      "Loss: 15.6755\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.07):\n",
      "  Theta for diagnosed: 0.067 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=34.18):\n",
      "  Theta for diagnosed: 0.102 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=33.19):\n",
      "  Theta for diagnosed: 0.106 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=31.03):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.66):\n",
      "  Theta for diagnosed: 0.119 ± 0.118\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.032\n",
      "\n",
      "Epoch 125\n",
      "Loss: 15.6689\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.18):\n",
      "  Theta for diagnosed: 0.067 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=34.42):\n",
      "  Theta for diagnosed: 0.102 ± 0.083\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=33.30):\n",
      "  Theta for diagnosed: 0.106 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 52 (signature 5, LR=31.09):\n",
      "  Theta for diagnosed: 0.057 ± 0.043\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.011\n",
      "\n",
      "Disease 260 (signature 8, LR=30.66):\n",
      "  Theta for diagnosed: 0.120 ± 0.119\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.032\n",
      "\n",
      "Epoch 126\n",
      "Loss: 15.6622\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.30):\n",
      "  Theta for diagnosed: 0.067 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=34.65):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Disease 269 (signature 8, LR=33.41):\n",
      "  Theta for diagnosed: 0.106 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.16):\n",
      "  Theta for diagnosed: 0.057 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 260 (signature 8, LR=30.67):\n",
      "  Theta for diagnosed: 0.120 ± 0.119\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.032\n",
      "\n",
      "Epoch 127\n",
      "Loss: 15.6562\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.41):\n",
      "  Theta for diagnosed: 0.067 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=34.88):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=33.52):\n",
      "  Theta for diagnosed: 0.106 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.22):\n",
      "  Theta for diagnosed: 0.057 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 260 (signature 8, LR=30.67):\n",
      "  Theta for diagnosed: 0.120 ± 0.120\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.033\n",
      "\n",
      "Epoch 128\n",
      "Loss: 15.6502\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.52):\n",
      "  Theta for diagnosed: 0.067 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=35.12):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=33.63):\n",
      "  Theta for diagnosed: 0.106 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.28):\n",
      "  Theta for diagnosed: 0.057 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 260 (signature 8, LR=30.68):\n",
      "  Theta for diagnosed: 0.120 ± 0.120\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.033\n",
      "\n",
      "Epoch 129\n",
      "Loss: 15.6437\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.64):\n",
      "  Theta for diagnosed: 0.067 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=35.35):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=33.74):\n",
      "  Theta for diagnosed: 0.106 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.34):\n",
      "  Theta for diagnosed: 0.057 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 260 (signature 8, LR=30.68):\n",
      "  Theta for diagnosed: 0.121 ± 0.121\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.033\n",
      "\n",
      "Epoch 130\n",
      "Loss: 15.6373\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.75):\n",
      "  Theta for diagnosed: 0.067 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=35.59):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=33.85):\n",
      "  Theta for diagnosed: 0.106 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.40):\n",
      "  Theta for diagnosed: 0.057 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 260 (signature 8, LR=30.69):\n",
      "  Theta for diagnosed: 0.121 ± 0.121\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.033\n",
      "\n",
      "Epoch 131\n",
      "Loss: 15.6312\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.86):\n",
      "  Theta for diagnosed: 0.067 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=35.83):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=33.96):\n",
      "  Theta for diagnosed: 0.106 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.47):\n",
      "  Theta for diagnosed: 0.057 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 260 (signature 8, LR=30.69):\n",
      "  Theta for diagnosed: 0.121 ± 0.122\n",
      "  Theta for others: 0.088\n",
      "  Proportion difference: 0.034\n",
      "\n",
      "Epoch 132\n",
      "Loss: 15.6251\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=41.97):\n",
      "  Theta for diagnosed: 0.067 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=36.07):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=34.07):\n",
      "  Theta for diagnosed: 0.107 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.53):\n",
      "  Theta for diagnosed: 0.057 ± 0.044\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=30.70):\n",
      "  Theta for diagnosed: 0.065 ± 0.053\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 133\n",
      "Loss: 15.6186\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.08):\n",
      "  Theta for diagnosed: 0.068 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 281 (signature 8, LR=36.31):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=34.19):\n",
      "  Theta for diagnosed: 0.107 ± 0.096\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 52 (signature 5, LR=31.59):\n",
      "  Theta for diagnosed: 0.058 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=30.84):\n",
      "  Theta for diagnosed: 0.065 ± 0.054\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 134\n",
      "Loss: 15.6123\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.19):\n",
      "  Theta for diagnosed: 0.068 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=36.55):\n",
      "  Theta for diagnosed: 0.102 ± 0.084\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=34.30):\n",
      "  Theta for diagnosed: 0.107 ± 0.096\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=31.65):\n",
      "  Theta for diagnosed: 0.058 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=30.98):\n",
      "  Theta for diagnosed: 0.065 ± 0.054\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 135\n",
      "Loss: 15.6062\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.29):\n",
      "  Theta for diagnosed: 0.068 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=36.80):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=34.41):\n",
      "  Theta for diagnosed: 0.107 ± 0.096\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=31.71):\n",
      "  Theta for diagnosed: 0.058 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=31.13):\n",
      "  Theta for diagnosed: 0.065 ± 0.054\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 136\n",
      "Loss: 15.6000\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.40):\n",
      "  Theta for diagnosed: 0.068 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=37.04):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=34.53):\n",
      "  Theta for diagnosed: 0.107 ± 0.097\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=31.77):\n",
      "  Theta for diagnosed: 0.058 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=31.27):\n",
      "  Theta for diagnosed: 0.065 ± 0.055\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 137\n",
      "Loss: 15.5936\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.51):\n",
      "  Theta for diagnosed: 0.068 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=37.28):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=34.64):\n",
      "  Theta for diagnosed: 0.107 ± 0.097\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=31.83):\n",
      "  Theta for diagnosed: 0.058 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=31.41):\n",
      "  Theta for diagnosed: 0.066 ± 0.055\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 138\n",
      "Loss: 15.5873\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.61):\n",
      "  Theta for diagnosed: 0.068 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=37.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.015\n",
      "\n",
      "Disease 269 (signature 8, LR=34.76):\n",
      "  Theta for diagnosed: 0.107 ± 0.097\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=31.89):\n",
      "  Theta for diagnosed: 0.058 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=31.56):\n",
      "  Theta for diagnosed: 0.066 ± 0.055\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 139\n",
      "Loss: 15.5811\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.72):\n",
      "  Theta for diagnosed: 0.068 ± 0.055\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=37.78):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=34.88):\n",
      "  Theta for diagnosed: 0.108 ± 0.097\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=31.95):\n",
      "  Theta for diagnosed: 0.058 ± 0.045\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=31.70):\n",
      "  Theta for diagnosed: 0.066 ± 0.055\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 140\n",
      "Loss: 15.5749\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.82):\n",
      "  Theta for diagnosed: 0.068 ± 0.055\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=38.03):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=34.99):\n",
      "  Theta for diagnosed: 0.108 ± 0.098\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.01):\n",
      "  Theta for diagnosed: 0.058 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=31.84):\n",
      "  Theta for diagnosed: 0.066 ± 0.056\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 141\n",
      "Loss: 15.5685\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=42.93):\n",
      "  Theta for diagnosed: 0.068 ± 0.055\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=38.28):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.11):\n",
      "  Theta for diagnosed: 0.108 ± 0.098\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.07):\n",
      "  Theta for diagnosed: 0.058 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=31.98):\n",
      "  Theta for diagnosed: 0.066 ± 0.056\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 142\n",
      "Loss: 15.5621\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.03):\n",
      "  Theta for diagnosed: 0.068 ± 0.056\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=38.53):\n",
      "  Theta for diagnosed: 0.103 ± 0.085\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.23):\n",
      "  Theta for diagnosed: 0.108 ± 0.098\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=32.13):\n",
      "  Theta for diagnosed: 0.058 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Disease 113 (signature 5, LR=32.13):\n",
      "  Theta for diagnosed: 0.066 ± 0.056\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Epoch 143\n",
      "Loss: 15.5559\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.13):\n",
      "  Theta for diagnosed: 0.068 ± 0.056\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=38.78):\n",
      "  Theta for diagnosed: 0.103 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.34):\n",
      "  Theta for diagnosed: 0.108 ± 0.098\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 113 (signature 5, LR=32.27):\n",
      "  Theta for diagnosed: 0.066 ± 0.056\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.19):\n",
      "  Theta for diagnosed: 0.058 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 144\n",
      "Loss: 15.5497\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.24):\n",
      "  Theta for diagnosed: 0.068 ± 0.056\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 281 (signature 8, LR=39.03):\n",
      "  Theta for diagnosed: 0.103 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.46):\n",
      "  Theta for diagnosed: 0.108 ± 0.099\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 113 (signature 5, LR=32.41):\n",
      "  Theta for diagnosed: 0.066 ± 0.057\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.25):\n",
      "  Theta for diagnosed: 0.058 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 145\n",
      "Loss: 15.5433\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.34):\n",
      "  Theta for diagnosed: 0.069 ± 0.056\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=39.28):\n",
      "  Theta for diagnosed: 0.103 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.58):\n",
      "  Theta for diagnosed: 0.108 ± 0.099\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 113 (signature 5, LR=32.55):\n",
      "  Theta for diagnosed: 0.066 ± 0.057\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.31):\n",
      "  Theta for diagnosed: 0.058 ± 0.046\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 146\n",
      "Loss: 15.5371\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.44):\n",
      "  Theta for diagnosed: 0.069 ± 0.057\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=39.54):\n",
      "  Theta for diagnosed: 0.104 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.70):\n",
      "  Theta for diagnosed: 0.108 ± 0.099\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 113 (signature 5, LR=32.69):\n",
      "  Theta for diagnosed: 0.066 ± 0.057\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.37):\n",
      "  Theta for diagnosed: 0.058 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 147\n",
      "Loss: 15.5309\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.54):\n",
      "  Theta for diagnosed: 0.069 ± 0.057\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=39.79):\n",
      "  Theta for diagnosed: 0.104 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.82):\n",
      "  Theta for diagnosed: 0.109 ± 0.100\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 113 (signature 5, LR=32.83):\n",
      "  Theta for diagnosed: 0.066 ± 0.058\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.43):\n",
      "  Theta for diagnosed: 0.058 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 148\n",
      "Loss: 15.5246\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.64):\n",
      "  Theta for diagnosed: 0.069 ± 0.057\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=40.05):\n",
      "  Theta for diagnosed: 0.104 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=35.94):\n",
      "  Theta for diagnosed: 0.109 ± 0.100\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 113 (signature 5, LR=32.97):\n",
      "  Theta for diagnosed: 0.067 ± 0.058\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.49):\n",
      "  Theta for diagnosed: 0.058 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 149\n",
      "Loss: 15.5183\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.74):\n",
      "  Theta for diagnosed: 0.069 ± 0.057\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=40.30):\n",
      "  Theta for diagnosed: 0.104 ± 0.086\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.016\n",
      "\n",
      "Disease 269 (signature 8, LR=36.06):\n",
      "  Theta for diagnosed: 0.109 ± 0.100\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 113 (signature 5, LR=33.11):\n",
      "  Theta for diagnosed: 0.067 ± 0.058\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.55):\n",
      "  Theta for diagnosed: 0.058 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 150\n",
      "Loss: 15.5120\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.84):\n",
      "  Theta for diagnosed: 0.069 ± 0.058\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=40.56):\n",
      "  Theta for diagnosed: 0.104 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=36.18):\n",
      "  Theta for diagnosed: 0.109 ± 0.100\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 113 (signature 5, LR=33.25):\n",
      "  Theta for diagnosed: 0.067 ± 0.058\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.61):\n",
      "  Theta for diagnosed: 0.058 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 151\n",
      "Loss: 15.5057\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=43.93):\n",
      "  Theta for diagnosed: 0.069 ± 0.058\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=40.82):\n",
      "  Theta for diagnosed: 0.104 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=36.30):\n",
      "  Theta for diagnosed: 0.109 ± 0.101\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 113 (signature 5, LR=33.38):\n",
      "  Theta for diagnosed: 0.067 ± 0.059\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.67):\n",
      "  Theta for diagnosed: 0.058 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.012\n",
      "\n",
      "Epoch 152\n",
      "Loss: 15.4995\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.03):\n",
      "  Theta for diagnosed: 0.069 ± 0.058\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=41.08):\n",
      "  Theta for diagnosed: 0.104 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=36.42):\n",
      "  Theta for diagnosed: 0.109 ± 0.101\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 113 (signature 5, LR=33.52):\n",
      "  Theta for diagnosed: 0.067 ± 0.059\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.73):\n",
      "  Theta for diagnosed: 0.058 ± 0.047\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 153\n",
      "Loss: 15.4932\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.13):\n",
      "  Theta for diagnosed: 0.069 ± 0.059\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=41.33):\n",
      "  Theta for diagnosed: 0.104 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=36.55):\n",
      "  Theta for diagnosed: 0.109 ± 0.101\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 113 (signature 5, LR=33.66):\n",
      "  Theta for diagnosed: 0.067 ± 0.059\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 52 (signature 5, LR=32.79):\n",
      "  Theta for diagnosed: 0.058 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 154\n",
      "Loss: 15.4869\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.22):\n",
      "  Theta for diagnosed: 0.069 ± 0.059\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=41.59):\n",
      "  Theta for diagnosed: 0.104 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=36.67):\n",
      "  Theta for diagnosed: 0.110 ± 0.102\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 113 (signature 5, LR=33.79):\n",
      "  Theta for diagnosed: 0.067 ± 0.060\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=32.85):\n",
      "  Theta for diagnosed: 0.058 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 155\n",
      "Loss: 15.4807\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.32):\n",
      "  Theta for diagnosed: 0.069 ± 0.059\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 281 (signature 8, LR=41.85):\n",
      "  Theta for diagnosed: 0.104 ± 0.087\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=36.79):\n",
      "  Theta for diagnosed: 0.110 ± 0.102\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 113 (signature 5, LR=33.93):\n",
      "  Theta for diagnosed: 0.067 ± 0.060\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=32.91):\n",
      "  Theta for diagnosed: 0.058 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 156\n",
      "Loss: 15.4745\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.42):\n",
      "  Theta for diagnosed: 0.069 ± 0.059\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=42.11):\n",
      "  Theta for diagnosed: 0.105 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=36.91):\n",
      "  Theta for diagnosed: 0.110 ± 0.102\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 113 (signature 5, LR=34.06):\n",
      "  Theta for diagnosed: 0.067 ± 0.060\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=32.97):\n",
      "  Theta for diagnosed: 0.058 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 157\n",
      "Loss: 15.4682\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.51):\n",
      "  Theta for diagnosed: 0.070 ± 0.060\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=42.37):\n",
      "  Theta for diagnosed: 0.105 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=37.04):\n",
      "  Theta for diagnosed: 0.110 ± 0.102\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 113 (signature 5, LR=34.20):\n",
      "  Theta for diagnosed: 0.067 ± 0.060\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=33.03):\n",
      "  Theta for diagnosed: 0.058 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 158\n",
      "Loss: 15.4619\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.61):\n",
      "  Theta for diagnosed: 0.070 ± 0.060\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=42.63):\n",
      "  Theta for diagnosed: 0.105 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.017\n",
      "\n",
      "Disease 269 (signature 8, LR=37.16):\n",
      "  Theta for diagnosed: 0.110 ± 0.103\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 113 (signature 5, LR=34.33):\n",
      "  Theta for diagnosed: 0.068 ± 0.061\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=33.09):\n",
      "  Theta for diagnosed: 0.058 ± 0.048\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 159\n",
      "Loss: 15.4556\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.70):\n",
      "  Theta for diagnosed: 0.070 ± 0.060\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=42.90):\n",
      "  Theta for diagnosed: 0.105 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=37.28):\n",
      "  Theta for diagnosed: 0.110 ± 0.103\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 113 (signature 5, LR=34.47):\n",
      "  Theta for diagnosed: 0.068 ± 0.061\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=33.15):\n",
      "  Theta for diagnosed: 0.058 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 160\n",
      "Loss: 15.4493\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.79):\n",
      "  Theta for diagnosed: 0.070 ± 0.061\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=43.16):\n",
      "  Theta for diagnosed: 0.105 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=37.41):\n",
      "  Theta for diagnosed: 0.110 ± 0.103\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 113 (signature 5, LR=34.60):\n",
      "  Theta for diagnosed: 0.068 ± 0.061\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=33.21):\n",
      "  Theta for diagnosed: 0.059 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 161\n",
      "Loss: 15.4430\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.89):\n",
      "  Theta for diagnosed: 0.070 ± 0.061\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=43.42):\n",
      "  Theta for diagnosed: 0.105 ± 0.088\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=37.53):\n",
      "  Theta for diagnosed: 0.111 ± 0.104\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 113 (signature 5, LR=34.73):\n",
      "  Theta for diagnosed: 0.068 ± 0.062\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=33.28):\n",
      "  Theta for diagnosed: 0.059 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 162\n",
      "Loss: 15.4369\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=44.98):\n",
      "  Theta for diagnosed: 0.070 ± 0.061\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=43.68):\n",
      "  Theta for diagnosed: 0.105 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=37.66):\n",
      "  Theta for diagnosed: 0.111 ± 0.104\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 113 (signature 5, LR=34.86):\n",
      "  Theta for diagnosed: 0.068 ± 0.062\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=33.34):\n",
      "  Theta for diagnosed: 0.059 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 163\n",
      "Loss: 15.4307\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=45.07):\n",
      "  Theta for diagnosed: 0.070 ± 0.062\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=43.94):\n",
      "  Theta for diagnosed: 0.105 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=37.78):\n",
      "  Theta for diagnosed: 0.111 ± 0.104\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 113 (signature 5, LR=34.99):\n",
      "  Theta for diagnosed: 0.068 ± 0.062\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 52 (signature 5, LR=33.40):\n",
      "  Theta for diagnosed: 0.059 ± 0.049\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 164\n",
      "Loss: 15.4244\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=45.16):\n",
      "  Theta for diagnosed: 0.070 ± 0.062\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=44.21):\n",
      "  Theta for diagnosed: 0.105 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=37.91):\n",
      "  Theta for diagnosed: 0.111 ± 0.104\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 113 (signature 5, LR=35.12):\n",
      "  Theta for diagnosed: 0.068 ± 0.063\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.46):\n",
      "  Theta for diagnosed: 0.059 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 165\n",
      "Loss: 15.4182\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=45.25):\n",
      "  Theta for diagnosed: 0.070 ± 0.062\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=44.47):\n",
      "  Theta for diagnosed: 0.106 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=38.03):\n",
      "  Theta for diagnosed: 0.111 ± 0.105\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 113 (signature 5, LR=35.25):\n",
      "  Theta for diagnosed: 0.068 ± 0.063\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.52):\n",
      "  Theta for diagnosed: 0.059 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 166\n",
      "Loss: 15.4120\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=45.35):\n",
      "  Theta for diagnosed: 0.070 ± 0.062\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 281 (signature 8, LR=44.73):\n",
      "  Theta for diagnosed: 0.106 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=38.16):\n",
      "  Theta for diagnosed: 0.111 ± 0.105\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 113 (signature 5, LR=35.38):\n",
      "  Theta for diagnosed: 0.068 ± 0.063\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.58):\n",
      "  Theta for diagnosed: 0.059 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 167\n",
      "Loss: 15.4057\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=45.44):\n",
      "  Theta for diagnosed: 0.070 ± 0.063\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 281 (signature 8, LR=45.00):\n",
      "  Theta for diagnosed: 0.106 ± 0.089\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=38.29):\n",
      "  Theta for diagnosed: 0.111 ± 0.105\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 113 (signature 5, LR=35.51):\n",
      "  Theta for diagnosed: 0.068 ± 0.064\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.65):\n",
      "  Theta for diagnosed: 0.059 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 168\n",
      "Loss: 15.3995\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=45.53):\n",
      "  Theta for diagnosed: 0.071 ± 0.063\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 281 (signature 8, LR=45.26):\n",
      "  Theta for diagnosed: 0.106 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.018\n",
      "\n",
      "Disease 269 (signature 8, LR=38.41):\n",
      "  Theta for diagnosed: 0.112 ± 0.106\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 113 (signature 5, LR=35.64):\n",
      "  Theta for diagnosed: 0.068 ± 0.064\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.71):\n",
      "  Theta for diagnosed: 0.059 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 169\n",
      "Loss: 15.3933\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 114 (signature 5, LR=45.62):\n",
      "  Theta for diagnosed: 0.071 ± 0.063\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 281 (signature 8, LR=45.52):\n",
      "  Theta for diagnosed: 0.106 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 269 (signature 8, LR=38.54):\n",
      "  Theta for diagnosed: 0.112 ± 0.106\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 113 (signature 5, LR=35.76):\n",
      "  Theta for diagnosed: 0.069 ± 0.064\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.77):\n",
      "  Theta for diagnosed: 0.059 ± 0.050\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 170\n",
      "Loss: 15.3870\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=45.79):\n",
      "  Theta for diagnosed: 0.106 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=45.71):\n",
      "  Theta for diagnosed: 0.071 ± 0.064\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=38.67):\n",
      "  Theta for diagnosed: 0.112 ± 0.106\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 113 (signature 5, LR=35.89):\n",
      "  Theta for diagnosed: 0.069 ± 0.064\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.83):\n",
      "  Theta for diagnosed: 0.059 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 171\n",
      "Loss: 15.3807\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=46.05):\n",
      "  Theta for diagnosed: 0.106 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=45.80):\n",
      "  Theta for diagnosed: 0.071 ± 0.064\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=38.79):\n",
      "  Theta for diagnosed: 0.112 ± 0.107\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 113 (signature 5, LR=36.01):\n",
      "  Theta for diagnosed: 0.069 ± 0.065\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.90):\n",
      "  Theta for diagnosed: 0.059 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 172\n",
      "Loss: 15.3745\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=46.31):\n",
      "  Theta for diagnosed: 0.106 ± 0.090\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=45.88):\n",
      "  Theta for diagnosed: 0.071 ± 0.064\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=38.92):\n",
      "  Theta for diagnosed: 0.112 ± 0.107\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 113 (signature 5, LR=36.14):\n",
      "  Theta for diagnosed: 0.069 ± 0.065\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=33.96):\n",
      "  Theta for diagnosed: 0.059 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 173\n",
      "Loss: 15.3683\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=46.58):\n",
      "  Theta for diagnosed: 0.106 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=45.97):\n",
      "  Theta for diagnosed: 0.071 ± 0.065\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=39.05):\n",
      "  Theta for diagnosed: 0.112 ± 0.107\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 113 (signature 5, LR=36.26):\n",
      "  Theta for diagnosed: 0.069 ± 0.065\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 52 (signature 5, LR=34.02):\n",
      "  Theta for diagnosed: 0.059 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 174\n",
      "Loss: 15.3621\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=46.84):\n",
      "  Theta for diagnosed: 0.107 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=46.06):\n",
      "  Theta for diagnosed: 0.071 ± 0.065\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=39.17):\n",
      "  Theta for diagnosed: 0.112 ± 0.108\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 113 (signature 5, LR=36.38):\n",
      "  Theta for diagnosed: 0.069 ± 0.066\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.09):\n",
      "  Theta for diagnosed: 0.059 ± 0.051\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 175\n",
      "Loss: 15.3561\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=47.10):\n",
      "  Theta for diagnosed: 0.107 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=46.15):\n",
      "  Theta for diagnosed: 0.071 ± 0.065\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=39.30):\n",
      "  Theta for diagnosed: 0.113 ± 0.108\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 113 (signature 5, LR=36.51):\n",
      "  Theta for diagnosed: 0.069 ± 0.066\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.15):\n",
      "  Theta for diagnosed: 0.059 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.013\n",
      "\n",
      "Epoch 176\n",
      "Loss: 15.3498\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=47.36):\n",
      "  Theta for diagnosed: 0.107 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=46.24):\n",
      "  Theta for diagnosed: 0.071 ± 0.065\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 269 (signature 8, LR=39.43):\n",
      "  Theta for diagnosed: 0.113 ± 0.108\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 113 (signature 5, LR=36.63):\n",
      "  Theta for diagnosed: 0.069 ± 0.066\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.21):\n",
      "  Theta for diagnosed: 0.059 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 177\n",
      "Loss: 15.3435\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=47.63):\n",
      "  Theta for diagnosed: 0.107 ± 0.091\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.019\n",
      "\n",
      "Disease 114 (signature 5, LR=46.32):\n",
      "  Theta for diagnosed: 0.071 ± 0.066\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=39.56):\n",
      "  Theta for diagnosed: 0.113 ± 0.108\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 113 (signature 5, LR=36.75):\n",
      "  Theta for diagnosed: 0.069 ± 0.067\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.28):\n",
      "  Theta for diagnosed: 0.059 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 178\n",
      "Loss: 15.3373\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=47.89):\n",
      "  Theta for diagnosed: 0.107 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=46.41):\n",
      "  Theta for diagnosed: 0.071 ± 0.066\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=39.68):\n",
      "  Theta for diagnosed: 0.113 ± 0.109\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 113 (signature 5, LR=36.87):\n",
      "  Theta for diagnosed: 0.069 ± 0.067\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.34):\n",
      "  Theta for diagnosed: 0.059 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 179\n",
      "Loss: 15.3311\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=48.15):\n",
      "  Theta for diagnosed: 0.107 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=46.50):\n",
      "  Theta for diagnosed: 0.072 ± 0.066\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=39.81):\n",
      "  Theta for diagnosed: 0.113 ± 0.109\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 113 (signature 5, LR=36.99):\n",
      "  Theta for diagnosed: 0.070 ± 0.067\n",
      "  Theta for others: 0.047\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.41):\n",
      "  Theta for diagnosed: 0.059 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 180\n",
      "Loss: 15.3247\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=48.41):\n",
      "  Theta for diagnosed: 0.107 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=46.58):\n",
      "  Theta for diagnosed: 0.072 ± 0.067\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=39.94):\n",
      "  Theta for diagnosed: 0.113 ± 0.109\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 113 (signature 5, LR=37.10):\n",
      "  Theta for diagnosed: 0.070 ± 0.068\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.47):\n",
      "  Theta for diagnosed: 0.059 ± 0.052\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 181\n",
      "Loss: 15.3184\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=48.67):\n",
      "  Theta for diagnosed: 0.107 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=46.67):\n",
      "  Theta for diagnosed: 0.072 ± 0.067\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=40.07):\n",
      "  Theta for diagnosed: 0.114 ± 0.110\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 113 (signature 5, LR=37.22):\n",
      "  Theta for diagnosed: 0.070 ± 0.068\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.54):\n",
      "  Theta for diagnosed: 0.059 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 182\n",
      "Loss: 15.3122\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=48.93):\n",
      "  Theta for diagnosed: 0.107 ± 0.092\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=46.76):\n",
      "  Theta for diagnosed: 0.072 ± 0.067\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=40.20):\n",
      "  Theta for diagnosed: 0.114 ± 0.110\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 113 (signature 5, LR=37.34):\n",
      "  Theta for diagnosed: 0.070 ± 0.068\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.60):\n",
      "  Theta for diagnosed: 0.059 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 183\n",
      "Loss: 15.3059\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=49.19):\n",
      "  Theta for diagnosed: 0.108 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=46.84):\n",
      "  Theta for diagnosed: 0.072 ± 0.068\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=40.32):\n",
      "  Theta for diagnosed: 0.114 ± 0.110\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 113 (signature 5, LR=37.45):\n",
      "  Theta for diagnosed: 0.070 ± 0.069\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.023\n",
      "\n",
      "Disease 52 (signature 5, LR=34.67):\n",
      "  Theta for diagnosed: 0.059 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 184\n",
      "Loss: 15.2996\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=49.45):\n",
      "  Theta for diagnosed: 0.108 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=46.93):\n",
      "  Theta for diagnosed: 0.072 ± 0.068\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=40.45):\n",
      "  Theta for diagnosed: 0.114 ± 0.111\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 113 (signature 5, LR=37.57):\n",
      "  Theta for diagnosed: 0.070 ± 0.069\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 52 (signature 5, LR=34.73):\n",
      "  Theta for diagnosed: 0.059 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 185\n",
      "Loss: 15.2933\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=49.71):\n",
      "  Theta for diagnosed: 0.108 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.020\n",
      "\n",
      "Disease 114 (signature 5, LR=47.01):\n",
      "  Theta for diagnosed: 0.072 ± 0.068\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=40.58):\n",
      "  Theta for diagnosed: 0.114 ± 0.111\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 113 (signature 5, LR=37.68):\n",
      "  Theta for diagnosed: 0.070 ± 0.069\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 52 (signature 5, LR=34.80):\n",
      "  Theta for diagnosed: 0.059 ± 0.053\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 186\n",
      "Loss: 15.2870\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=49.97):\n",
      "  Theta for diagnosed: 0.108 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.10):\n",
      "  Theta for diagnosed: 0.072 ± 0.069\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=40.71):\n",
      "  Theta for diagnosed: 0.114 ± 0.111\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 113 (signature 5, LR=37.80):\n",
      "  Theta for diagnosed: 0.070 ± 0.070\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 52 (signature 5, LR=34.86):\n",
      "  Theta for diagnosed: 0.060 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 187\n",
      "Loss: 15.2807\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=50.23):\n",
      "  Theta for diagnosed: 0.108 ± 0.093\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.19):\n",
      "  Theta for diagnosed: 0.072 ± 0.069\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.026\n",
      "\n",
      "Disease 269 (signature 8, LR=40.84):\n",
      "  Theta for diagnosed: 0.114 ± 0.112\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 113 (signature 5, LR=37.91):\n",
      "  Theta for diagnosed: 0.070 ± 0.070\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 52 (signature 5, LR=34.93):\n",
      "  Theta for diagnosed: 0.060 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 188\n",
      "Loss: 15.2744\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=50.49):\n",
      "  Theta for diagnosed: 0.108 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.27):\n",
      "  Theta for diagnosed: 0.072 ± 0.069\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=40.97):\n",
      "  Theta for diagnosed: 0.115 ± 0.112\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 113 (signature 5, LR=38.02):\n",
      "  Theta for diagnosed: 0.070 ± 0.070\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 52 (signature 5, LR=35.00):\n",
      "  Theta for diagnosed: 0.060 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 189\n",
      "Loss: 15.2682\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=50.74):\n",
      "  Theta for diagnosed: 0.108 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.35):\n",
      "  Theta for diagnosed: 0.073 ± 0.070\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.09):\n",
      "  Theta for diagnosed: 0.115 ± 0.112\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 113 (signature 5, LR=38.13):\n",
      "  Theta for diagnosed: 0.071 ± 0.071\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 52 (signature 5, LR=35.06):\n",
      "  Theta for diagnosed: 0.060 ± 0.054\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.014\n",
      "\n",
      "Epoch 190\n",
      "Loss: 15.2621\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=51.00):\n",
      "  Theta for diagnosed: 0.108 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.44):\n",
      "  Theta for diagnosed: 0.073 ± 0.070\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.22):\n",
      "  Theta for diagnosed: 0.115 ± 0.113\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 113 (signature 5, LR=38.24):\n",
      "  Theta for diagnosed: 0.071 ± 0.071\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 39 (signature 19, LR=35.21):\n",
      "  Theta for diagnosed: 0.050 ± 0.017\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 191\n",
      "Loss: 15.2558\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=51.26):\n",
      "  Theta for diagnosed: 0.109 ± 0.094\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.52):\n",
      "  Theta for diagnosed: 0.073 ± 0.070\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.35):\n",
      "  Theta for diagnosed: 0.115 ± 0.113\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 113 (signature 5, LR=38.35):\n",
      "  Theta for diagnosed: 0.071 ± 0.071\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 39 (signature 19, LR=35.36):\n",
      "  Theta for diagnosed: 0.050 ± 0.017\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 192\n",
      "Loss: 15.2495\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=51.51):\n",
      "  Theta for diagnosed: 0.109 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.61):\n",
      "  Theta for diagnosed: 0.073 ± 0.070\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.48):\n",
      "  Theta for diagnosed: 0.115 ± 0.113\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 113 (signature 5, LR=38.46):\n",
      "  Theta for diagnosed: 0.071 ± 0.072\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 39 (signature 19, LR=35.52):\n",
      "  Theta for diagnosed: 0.050 ± 0.017\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 193\n",
      "Loss: 15.2433\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=51.77):\n",
      "  Theta for diagnosed: 0.109 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.021\n",
      "\n",
      "Disease 114 (signature 5, LR=47.69):\n",
      "  Theta for diagnosed: 0.073 ± 0.071\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.61):\n",
      "  Theta for diagnosed: 0.115 ± 0.113\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 113 (signature 5, LR=38.57):\n",
      "  Theta for diagnosed: 0.071 ± 0.072\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.024\n",
      "\n",
      "Disease 39 (signature 19, LR=35.68):\n",
      "  Theta for diagnosed: 0.050 ± 0.018\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 194\n",
      "Loss: 15.2371\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=52.02):\n",
      "  Theta for diagnosed: 0.109 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 114 (signature 5, LR=47.78):\n",
      "  Theta for diagnosed: 0.073 ± 0.071\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.74):\n",
      "  Theta for diagnosed: 0.115 ± 0.114\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 113 (signature 5, LR=38.67):\n",
      "  Theta for diagnosed: 0.071 ± 0.072\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 39 (signature 19, LR=35.83):\n",
      "  Theta for diagnosed: 0.050 ± 0.018\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 195\n",
      "Loss: 15.2308\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=52.27):\n",
      "  Theta for diagnosed: 0.109 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 114 (signature 5, LR=47.86):\n",
      "  Theta for diagnosed: 0.073 ± 0.071\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.86):\n",
      "  Theta for diagnosed: 0.116 ± 0.114\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 113 (signature 5, LR=38.78):\n",
      "  Theta for diagnosed: 0.071 ± 0.073\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 39 (signature 19, LR=35.99):\n",
      "  Theta for diagnosed: 0.050 ± 0.018\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 196\n",
      "Loss: 15.2245\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=52.53):\n",
      "  Theta for diagnosed: 0.109 ± 0.095\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 114 (signature 5, LR=47.95):\n",
      "  Theta for diagnosed: 0.073 ± 0.072\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=41.99):\n",
      "  Theta for diagnosed: 0.116 ± 0.114\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 113 (signature 5, LR=38.88):\n",
      "  Theta for diagnosed: 0.071 ± 0.073\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 39 (signature 19, LR=36.15):\n",
      "  Theta for diagnosed: 0.050 ± 0.018\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 197\n",
      "Loss: 15.2184\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=52.78):\n",
      "  Theta for diagnosed: 0.109 ± 0.096\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 114 (signature 5, LR=48.03):\n",
      "  Theta for diagnosed: 0.073 ± 0.072\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.027\n",
      "\n",
      "Disease 269 (signature 8, LR=42.12):\n",
      "  Theta for diagnosed: 0.116 ± 0.115\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 113 (signature 5, LR=38.99):\n",
      "  Theta for diagnosed: 0.071 ± 0.073\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 39 (signature 19, LR=36.31):\n",
      "  Theta for diagnosed: 0.050 ± 0.018\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 198\n",
      "Loss: 15.2121\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=53.03):\n",
      "  Theta for diagnosed: 0.109 ± 0.096\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 114 (signature 5, LR=48.11):\n",
      "  Theta for diagnosed: 0.073 ± 0.072\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 269 (signature 8, LR=42.25):\n",
      "  Theta for diagnosed: 0.116 ± 0.115\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 113 (signature 5, LR=39.09):\n",
      "  Theta for diagnosed: 0.071 ± 0.074\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 39 (signature 19, LR=36.48):\n",
      "  Theta for diagnosed: 0.050 ± 0.019\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "\n",
      "Epoch 199\n",
      "Loss: 15.2058\n",
      "\n",
      "Monitoring signature responses:\n",
      "\n",
      "Disease 281 (signature 8, LR=53.28):\n",
      "  Theta for diagnosed: 0.110 ± 0.096\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.022\n",
      "\n",
      "Disease 114 (signature 5, LR=48.20):\n",
      "  Theta for diagnosed: 0.073 ± 0.073\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.028\n",
      "\n",
      "Disease 269 (signature 8, LR=42.38):\n",
      "  Theta for diagnosed: 0.116 ± 0.115\n",
      "  Theta for others: 0.087\n",
      "  Proportion difference: 0.029\n",
      "\n",
      "Disease 113 (signature 5, LR=39.20):\n",
      "  Theta for diagnosed: 0.072 ± 0.074\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.025\n",
      "\n",
      "Disease 39 (signature 19, LR=36.64):\n",
      "  Theta for diagnosed: 0.050 ± 0.019\n",
      "  Theta for others: 0.046\n",
      "  Proportion difference: 0.004\n",
      "         93988578 function calls (93967727 primitive calls) in 4782.040 seconds\n",
      "\n",
      "   Ordered by: cumulative time\n",
      "   List reduced from 4183 to 20 due to restriction <20>\n",
      "\n",
      "   ncalls  tottime  percall  cumtime  percall filename:lineno(function)\n",
      "        2    0.000    0.000 4782.040 2391.020 /opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/IPython/core/interactiveshell.py:3514(run_code)\n",
      "   1885/2    0.033    0.000 4782.040 2391.020 {built-in method builtins.exec}\n",
      "        1    0.618    0.618 4782.040 4782.040 /var/folders/fl/ng5crz0x0fnb6c6x8dk7tfth0000gn/T/ipykernel_96024/2686668696.py:9(<module>)\n",
      "        1  134.853  134.853 4781.422 4781.422 /Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:329(fit)\n",
      "      200    0.008    0.000 3605.255   18.026 /opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/torch/_tensor.py:525(backward)\n",
      "      200    0.002    0.000 3605.247   18.026 /opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/torch/autograd/__init__.py:242(backward)\n",
      "      200    0.002    0.000 3605.236   18.026 /opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/torch/autograd/graph.py:816(_engine_run_backward)\n",
      "      200 3605.234   18.026 3605.234   18.026 {method 'run_backward' of 'torch._C._EngineBase' objects}\n",
      "      200  159.195    0.796 1008.505    5.043 /Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:230(compute_loss)\n",
      "      200  391.286    1.956  769.056    3.845 /Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:287(compute_gp_prior_loss)\n",
      " 43461600  270.846    0.000  270.846    0.000 {built-in method torch.cholesky_solve}\n",
      " 43531800  115.324    0.000  116.166    0.000 {built-in method torch.sum}\n",
      "      400   12.579    0.031   53.576    0.134 /Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:221(forward)\n",
      "      200    0.958    0.005   31.092    0.155 /Users/sarahurbut/aladynoulli2/pyScripts/clust_huge_amp.py:403(analyze_signature_responses)\n",
      "      400    0.005    0.000   29.065    0.073 /opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/torch/functional.py:210(einsum)\n",
      "      400   29.058    0.073   29.058    0.073 {built-in method torch.einsum}\n",
      "      600   23.351    0.039   23.351    0.039 {built-in method torch.log}\n",
      "      600   15.645    0.026   15.645    0.026 {built-in method torch.clamp}\n",
      "      600    0.003    0.000   10.984    0.018 /opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/torch/_tensor.py:33(wrapped)\n",
      "      600    0.003    0.000   10.981    0.018 /opt/miniconda3/envs/new_env_pyro2/lib/python3.9/site-packages/torch/_tensor.py:1026(__rsub__)\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<pstats.Stats at 0x113fefa00>"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import cProfile\n",
    "import pstats\n",
    "from pstats import SortKey\n",
    "\n",
    "# For the healthtoo version\n",
    "profiler = cProfile.Profile()\n",
    "profiler.enable()\n",
    "\n",
    "history_new = model.fit(E_enrollment, num_epochs=200, learning_rate=1e-1, lambda_reg=1e-2)\n",
    "profiler.disable()\n",
    "stats = pstats.Stats(profiler).sort_stats(SortKey.CUMULATIVE)\n",
    "stats.print_stats(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x500 with 3 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from utils import *\n",
    "plot_training_evolution(history_new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 131,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Get predictions (pi) from the model\n",
    "with torch.no_grad():\n",
    "    pi, _, _ = model.forward()  # pi shape: (N, D, T)\n",
    "\n",
    "\n",
    "\n",
    "Y_test = model.Y\n",
    "test_start=20000\n",
    "test_end=30000\n",
    "FH_test = fh_processed.iloc[test_start:test_end].reset_index(drop=True)\n",
    "# For each subject, get their enrollment age (from your covariate DataFrame)\n",
    "# Suppose FH_train is your DataFrame for the training set (reset index to match order)\n",
    "aladynoulli_1yr_risk_test = []\n",
    "for i, row in FH_test.iterrows():\n",
    "    enroll_time = int(row['age'] - 30)\n",
    "    # Choose the disease indices you want (e.g., ASCVD indices)\n",
    "    # For a single disease: d_idx = ...\n",
    "    # For a group: d_indices = [...]\n",
    "    # Example for ASCVD:\n",
    "    d_indices = [111, 112, 113, 114, 115, 116]  # adjust as needed\n",
    "    if enroll_time < 0 or enroll_time >= pi.shape[2]:\n",
    "        aladynoulli_1yr_risk_train.append(np.nan)\n",
    "        continue\n",
    "    # 1-year risk for ASCVD group at enrollment\n",
    "    pi_diseases = pi[i, d_indices, enroll_time]\n",
    "    yearly_risk = 1 - torch.prod(1 - pi_diseases)\n",
    "    aladynoulli_1yr_risk_test.append(yearly_risk.item())\n",
    "\n",
    "import numpy as np\n",
    "import torch\n",
    "ascvd_indices=[111,112,113,114,115,116]\n",
    "cases = []\n",
    "controls = []\n",
    "for i in range(len(FH_test)):\n",
    "    age = FH_test.iloc[i]['age']\n",
    "    t_enroll = int(age - 30)\n",
    "    if t_enroll < 0 or t_enroll >= Y_test.shape[2]:\n",
    "        continue\n",
    "    end_time = min(t_enroll + 10, Y_test.shape[2])\n",
    "    had_event = 0\n",
    "    for d_idx in ascvd_indices:\n",
    "        if torch.any(Y_test[i, d_idx, t_enroll:end_time] > 0):\n",
    "            had_event = 1\n",
    "            break\n",
    "    if had_event:\n",
    "        cases.append(aladynoulli_1yr_risk_test[i])\n",
    "    else:\n",
    "        controls.append(aladynoulli_1yr_risk_test[i])\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "plt.figure(figsize=(8, 5))\n",
    "sns.histplot(cases, color='red', label='ASCVD Case', kde=True, stat='density', bins=30, alpha=0.6)\n",
    "sns.histplot(controls, color='blue', label='Control', kde=True, stat='density', bins=30, alpha=0.6)\n",
    "plt.xlabel('Aladynoulli 1-year risk')\n",
    "plt.ylabel('Density')\n",
    "plt.title('Distribution of Aladynoulli 1-year risk for ASCVD Cases vs Controls')\n",
    "plt.legend()\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [],
   "source": [
    "\n",
    "# Save model\n",
    "W=0.0001\n",
    "torch.save({\n",
    "    'model_state_dict': model.state_dict(),\n",
    "    'E':E_enrollment,\n",
    "    'phi': model.phi,\n",
    "    'Y': model.Y,\n",
    "    'prevalence_t': model.prevalence_t,\n",
    "    'logit_prevalence_t': model.logit_prev_t,\n",
    "    'G': model.G,\n",
    "}, f'/Users/sarahurbut/Library/CloudStorage/Dropbox/enrollment_model_W{W}_jointphi_sexspecific_20000_30000.pt')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "metadata": {
    "vscode": {
     "languageId": "shellscript"
    }
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x1000 with 6 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "plot_theta_differences(model, diseases=[112,67,127,10,17,114], signatures=[5,7,0,17,19,5])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.21"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
